162 related articles for article (PubMed ID: 20597077)
21. [Status of determining the transepithelial potential difference (PD) of the respiratory epithelium in the diagnosis of mucoviscidosis].
Unal-Maelger OH; Urbanek R
Monatsschr Kinderheilkd; 1988 Feb; 136(2):76-80. PubMed ID: 2452977
[TBL] [Abstract][Full Text] [Related]
22. [Benzamil and mucoviscidosis. Primary culture of nasal mucosa as an electrophysiologic in vitro model].
Blank U; Glanz H; Eistert B; Fryen A; Lindemann H; Hüls G; Clauss W; Weber WM
HNO; 1996 Apr; 44(4):172-7. PubMed ID: 8655347
[TBL] [Abstract][Full Text] [Related]
23. Transepithelial nasal potential difference (NPD) measurements in cystic fibrosis (CF).
Sands D
Med Wieku Rozwoj; 2013; 17(1):13-7. PubMed ID: 23749691
[TBL] [Abstract][Full Text] [Related]
24. Hyperabsorption of Na+ and raised Ca(2+)-mediated Cl- secretion in nasal epithelia of CF mice.
Grubb BR; Vick RN; Boucher RC
Am J Physiol; 1994 May; 266(5 Pt 1):C1478-83. PubMed ID: 7515571
[TBL] [Abstract][Full Text] [Related]
25. Basic protocol for transepithelial nasal potential difference measurements.
Schüler D; Sermet-Gaudelus I; Wilschanski M; Ballmann M; Dechaux M; Edelman A; Hug M; Leal T; Lebacq J; Lebecque P; Lenoir G; Stanke F; Wallemacq P; Tümmler B; Knowles MR
J Cyst Fibros; 2004 Aug; 3 Suppl 2():151-5. PubMed ID: 15463949
[TBL] [Abstract][Full Text] [Related]
26. Evidence for reduced Cl- and increased Na+ permeability in cystic fibrosis human primary cell cultures.
Boucher RC; Cotton CU; Gatzy JT; Knowles MR; Yankaskas JR
J Physiol; 1988 Nov; 405():77-103. PubMed ID: 3255805
[TBL] [Abstract][Full Text] [Related]
27. Analysis of cystic fibrosis gener product (CFTR) function in patients with pancreas divisum and recurrent acute pancreatitis.
Gelrud A; Sheth S; Banerjee S; Weed D; Shea J; Chuttani R; Howell DA; Telford JJ; Carr-Locke DL; Regan MM; Ellis L; Durie PR; Freedman SD
Am J Gastroenterol; 2004 Aug; 99(8):1557-62. PubMed ID: 15307877
[TBL] [Abstract][Full Text] [Related]
28. Exercise reduces airway sodium ion reabsorption in cystic fibrosis but not in exercise asthma.
Schmitt L; Wiebel M; Frese F; Dehnert C; Zugck C; Bärtsch P; Mairbäurl H
Eur Respir J; 2011 Feb; 37(2):342-8. PubMed ID: 20525718
[TBL] [Abstract][Full Text] [Related]
29. Conventional and modified nasal potential-difference measurement in cystic fibrosis.
Höfmann T; Bohmer O; Hüls G; Terbrack HG; Bittner P; Klingmüller V; Heerd E; Lindemann H
Am J Respir Crit Care Med; 1997 Jun; 155(6):1908-13. PubMed ID: 9196094
[TBL] [Abstract][Full Text] [Related]
30. Nasal potential measurements on the nasal floor and under the inferior turbinate: does it matter?
Vermeulen F; Proesmans M; Feyaerts N; De Boeck K
Pediatr Pulmonol; 2011 Feb; 46(2):145-52. PubMed ID: 20865746
[TBL] [Abstract][Full Text] [Related]
31. Aldosterone metabolism and transepithelial potential difference in normal and cystic fibrosis subjects.
Knowles MR; Gatzy JT; Boucher RC
Pediatr Res; 1985 Jul; 19(7):676-9. PubMed ID: 4022674
[TBL] [Abstract][Full Text] [Related]
32. Effects of topically delivered benzamil and amiloride on nasal potential difference in cystic fibrosis.
Hofmann T; Stutts MJ; Ziersch A; Rückes C; Weber WM; Knowles MR; Lindemann H; Boucher RC
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1844-9. PubMed ID: 9620916
[TBL] [Abstract][Full Text] [Related]
33. Oxygen consumption and ouabain binding sites in cystic fibrosis nasal epithelium.
Stutts MJ; Knowles MR; Gatzy JT; Boucher RC
Pediatr Res; 1986 Dec; 20(12):1316-20. PubMed ID: 2432456
[TBL] [Abstract][Full Text] [Related]
34. Nasal airway ion transport is linked to the cystic fibrosis phenotype in adult patients.
Fajac I; Hubert D; Guillemot D; Honoré I; Bienvenu T; Volter F; Dall'Ava-Santucci J; Dusser DJ
Thorax; 2004 Nov; 59(11):971-6. PubMed ID: 15516474
[TBL] [Abstract][Full Text] [Related]
35. Exercise inhibits epithelial sodium channels in patients with cystic fibrosis.
Hebestreit A; Kersting U; Basler B; Jeschke R; Hebestreit H
Am J Respir Crit Care Med; 2001 Aug; 164(3):443-6. PubMed ID: 11500347
[TBL] [Abstract][Full Text] [Related]
36. Increased nasal potential difference and amiloride sensitivity in neonates with cystic fibrosis.
Gowen CW; Lawson EE; Gingras-Leatherman J; Gatzy JT; Boucher RC; Knowles MR
J Pediatr; 1986 Apr; 108(4):517-21. PubMed ID: 3958823
[TBL] [Abstract][Full Text] [Related]
37. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis.
Knowles M; Gatzy J; Boucher R
N Engl J Med; 1981 Dec; 305(25):1489-95. PubMed ID: 7300874
[TBL] [Abstract][Full Text] [Related]
38. A new device for in vivo measurement of nasal transepithelial potential difference in cystic fibrosis patients and normal subjects.
Duperrex O; Berclaz PY; Bertrand D; Lacroix JS; Pochon N; Belli D; Rochat T
Eur Respir J; 1997 Jul; 10(7):1631-6. PubMed ID: 9230258
[TBL] [Abstract][Full Text] [Related]
39. WNK4 regulates airway Na+ transport: study of familial hyperkalaemia and hypertension.
Farfel Z; Mayan H; Yaacov Y; Mouallem M; Shaharabany M; Pauzner R; Kerem E; Wilschanski M
Eur J Clin Invest; 2005 Jun; 35(6):410-5. PubMed ID: 15948903
[TBL] [Abstract][Full Text] [Related]
40. Nasal potential difference measurements in patients with atypical cystic fibrosis.
Wilschanski M; Famini H; Strauss-Liviatan N; Rivlin J; Blau H; Bibi H; Bentur L; Yahav Y; Springer H; Kramer MR; Klar A; Ilani A; Kerem B; Kerem E
Eur Respir J; 2001 Jun; 17(6):1208-15. PubMed ID: 11491166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
